Royal Bank of Canada
AMYT

Royal Bank of Canada’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Royal Bank of Canada’s Portfolio AMYT Stock Details AMYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,732
Closed -$25K – 7990
2023
Q1 		$25K Sell
1,732
-1,265
-42% -$17.9K ﹤0.01% 5955
2022
Q4 		$22K Sell
2,997
-8,300
-73% -$58.5K ﹤0.01% 6272
2022
Q3 		$78K Buy
11,297
+11,280
+66,353% +$84.2K ﹤0.01% 5480
2022
Q2 		$0 Sell
17
-116
-87% -$905 ﹤0.01% 7998
2022
Q1 		$1K Hold
133
– – ﹤0.01% 7661
2021
Q4 		$1K Sell
133
-244
-65% -$2.63K ﹤0.01% 7582
2021
Q3 		$4K Buy
377
+332
+738% +$3.75K ﹤0.01% 7224
2021
Q2 		$1K Buy
45
+2
+5% +$25 ﹤0.01% 7390
2021
Q1 		$1K Buy
+43
New +$601 ﹤0.01% 7352

Royal Bank of Canada's AMYT Position: Q2 2023 in Review

Royal Bank of Canada sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 1,732 shares — an estimated $25K sold.

Royal Bank of Canada first reported a position in AMYT in Q1 2021 and held it in 9 quarters. The position peaked at $78K in Q3 2022. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Royal Bank of Canada reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 1,732 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $25K.
  • Royal Bank of Canada first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2021 and held it in 9 quarters.
  • Royal Bank of Canada's Amryt Pharma plc American Depositary Shares position peaked at $78K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.